ASND 6-K: SEC filing
Ascendis Pharma
Filed with the SEC on · accession 0001612042-26-000024
ASND filed a 6-K (foreign company report) with the SEC on Nov 12, 2026. How foreign companies listed in the US report news and events — like an 8-K for them. The stock moved +1.4% by the first close after the filing.
Summary of the filing
Ascendis Pharma filed its Q3 2026 interim report on Form 6-K, covering the period ended September 30, 2026, including financial statements and notes on revenue, share repurchases, and convertible notes.
Key details
How ASND stock reacted
Close before
$259.28
Nov 11, 2026
First close after
+1.44%
$263.02
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for ASND, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ASND?
Click hereFrequently asked questions
What did ASND file with the SEC on Nov 12, 2026?
ASND filed a 6-K (SEC filing). Ascendis Pharma filed its Q3 2026 interim report on Form 6-K, covering the period ended September 30, 2026, including financial statements and notes on revenue, share repurchases, and convertible notes.
How do I read a 6-K?
How foreign companies listed in the US report news and events — like an 8-K for them. Look at the exhibit names: "results", "resign", "notice" tell you the topic. Many 6-Ks are routine (meeting notices); results and leadership changes matter most.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 6-K (foreign company report): How foreign companies listed in the US report news and events — like an 8-K for them.
How did ASND stock react to this filing?
ASND closed at $259.28 before the filing and $263.02 on Nov 12, 2026 (+1.44%).
Other ASND SEC filings
- 6-K · SEC filingNov 12, 2026
- 6-K · Fda approvalNov 6, 2026
- SCHEDULE 13G/A · SEC filingNov 5, 2026
- 6-K · Fda approvalOct 26, 2026
- 6-K · Fda approvalOct 16, 2026
- 6-K · SEC filingOct 14, 2026
- 6-K · SEC filingSep 29, 2026
- 6-K · Contract terminationSep 15, 2026
- 6-K · BuybackSep 15, 2026
- 6-K · SEC filingSep 9, 2026
Get alerts when ASND files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days